nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—osteoporosis	0.42	1	CbGaD
Cyproterone acetate—AR—Ergocalciferol—osteoporosis	0.184	0.475	CbGbCtD
Cyproterone acetate—CYP19A1—Raloxifene—osteoporosis	0.108	0.278	CbGbCtD
Cyproterone acetate—AR—Estradiol—osteoporosis	0.0956	0.247	CbGbCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—SHBG—osteoporosis	0.00147	0.0607	CbGpPWpGaD
Cyproterone acetate—Ethynodiol—ESR1—osteoporosis	0.00122	0.486	CrCbGaD
Cyproterone acetate—CYP19A1—Endogenous sterols—CYP27A1—osteoporosis	0.00102	0.0421	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.00085	0.0352	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000843	0.0349	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—SHBG—osteoporosis	0.000767	0.306	CrCbGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—GSN—osteoporosis	0.000761	0.0315	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PARK7—osteoporosis	0.000562	0.0233	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—osteoporosis	0.000518	0.207	CrCbGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—BGLAP—osteoporosis	0.000483	0.02	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000473	0.0196	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000466	0.0193	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—ESR2—osteoporosis	0.000458	0.0189	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—ESR2—osteoporosis	0.000452	0.0187	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000383	0.0159	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—VDR—osteoporosis	0.000363	0.015	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000362	0.015	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000361	0.0149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—VDR—osteoporosis	0.000359	0.0148	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000349	0.0144	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000347	0.0144	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—DKK1—osteoporosis	0.000343	0.0142	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000342	0.0141	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Endogenous sterols—POMC—osteoporosis	0.000321	0.0133	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000307	0.0127	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000305	0.0126	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000297	0.0123	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000292	0.0121	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000287	0.0119	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—ESR1—osteoporosis	0.000278	0.0115	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000276	0.0114	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000274	0.0114	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000274	0.0113	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000258	0.0107	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.000257	0.0107	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—ESR1—osteoporosis	0.000247	0.0102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000241	0.00996	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.000235	0.00971	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000219	0.00908	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000218	0.00902	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000213	0.00883	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000213	0.00883	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000211	0.00872	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.000211	0.00872	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP27A1—osteoporosis	0.000203	0.00842	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000201	0.00831	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000198	0.00821	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000184	0.0076	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000177	0.00732	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—WNT1—osteoporosis	0.00017	0.00704	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000166	0.00689	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000162	0.0067	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.000158	0.00654	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—BMP2—osteoporosis	0.000154	0.00637	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000152	0.00627	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.00015	0.00623	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000149	0.00617	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000148	0.00612	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	0.000138	0.00571	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000136	0.00563	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	0.000129	0.00535	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000129	0.00534	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000128	0.00528	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000126	0.00521	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000121	0.00501	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000115	0.00476	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000112	0.00464	CbGpPWpGaD
Cyproterone acetate—Shock—Risedronate—osteoporosis	0.000107	0.000647	CcSEcCtD
Cyproterone acetate—Anaemia—Zoledronate—osteoporosis	0.000107	0.000646	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Risedronate—osteoporosis	0.000107	0.000644	CcSEcCtD
Cyproterone acetate—Discomfort—Pamidronate—osteoporosis	0.000107	0.000644	CcSEcCtD
Cyproterone acetate—Agitation—Zoledronate—osteoporosis	0.000107	0.000643	CcSEcCtD
Cyproterone acetate—Skin disorder—Risedronate—osteoporosis	0.000106	0.000638	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Calcitriol—osteoporosis	0.000106	0.000638	CcSEcCtD
Cyproterone acetate—Body temperature increased—Raloxifene—osteoporosis	0.000106	0.000637	CcSEcCtD
Cyproterone acetate—Abdominal pain—Raloxifene—osteoporosis	0.000106	0.000637	CcSEcCtD
Cyproterone acetate—Urticaria—Ibandronate—osteoporosis	0.000105	0.000633	CcSEcCtD
Cyproterone acetate—Malaise—Zoledronate—osteoporosis	0.000105	0.000631	CcSEcCtD
Cyproterone acetate—Abdominal pain—Ibandronate—osteoporosis	0.000105	0.00063	CcSEcCtD
Cyproterone acetate—Body temperature increased—Ibandronate—osteoporosis	0.000105	0.00063	CcSEcCtD
Cyproterone acetate—Syncope—Zoledronate—osteoporosis	0.000104	0.000627	CcSEcCtD
Cyproterone acetate—Leukopenia—Zoledronate—osteoporosis	0.000104	0.000626	CcSEcCtD
Cyproterone acetate—Oedema—Pamidronate—osteoporosis	0.000104	0.000625	CcSEcCtD
Cyproterone acetate—Haemoglobin—Estradiol—osteoporosis	0.000103	0.000622	CcSEcCtD
Cyproterone acetate—Urticaria—Calcitriol—osteoporosis	0.000103	0.00062	CcSEcCtD
Cyproterone acetate—Haemorrhage—Estradiol—osteoporosis	0.000103	0.000619	CcSEcCtD
Cyproterone acetate—Hepatitis—Estradiol—osteoporosis	0.000103	0.000619	CcSEcCtD
Cyproterone acetate—Body temperature increased—Calcitriol—osteoporosis	0.000103	0.000617	CcSEcCtD
Cyproterone acetate—Abdominal pain—Calcitriol—osteoporosis	0.000103	0.000617	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.000102	0.00424	CbGpPWpGaD
Cyproterone acetate—Shock—Pamidronate—osteoporosis	0.000102	0.000615	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Zoledronate—osteoporosis	0.000102	0.000615	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Estropipate—osteoporosis	0.000102	0.000613	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Pamidronate—osteoporosis	0.000102	0.000613	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Pamidronate—osteoporosis	0.000102	0.000612	CcSEcCtD
Cyproterone acetate—Vomiting—Etidronic acid—osteoporosis	0.000102	0.000611	CcSEcCtD
Cyproterone acetate—Cough—Zoledronate—osteoporosis	0.000101	0.00061	CcSEcCtD
Cyproterone acetate—Tachycardia—Pamidronate—osteoporosis	0.000101	0.00061	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Estradiol—osteoporosis	0.000101	0.000608	CcSEcCtD
Cyproterone acetate—Rash—Etidronic acid—osteoporosis	0.000101	0.000606	CcSEcCtD
Cyproterone acetate—Dermatitis—Etidronic acid—osteoporosis	0.000101	0.000606	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Pamidronate—osteoporosis	0.0001	0.000604	CcSEcCtD
Cyproterone acetate—Syncope—Conjugated Estrogens—osteoporosis	0.0001	0.000604	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Alendronate—osteoporosis	0.0001	0.000603	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.0001	0.00415	CbGpPWpGaD
Cyproterone acetate—Headache—Etidronic acid—osteoporosis	0.0001	0.000602	CcSEcCtD
Cyproterone acetate—Asthenia—Estropipate—osteoporosis	9.92e-05	0.000597	CcSEcCtD
Cyproterone acetate—Visual impairment—Estradiol—osteoporosis	9.92e-05	0.000597	CcSEcCtD
Cyproterone acetate—Anorexia—Pamidronate—osteoporosis	9.9e-05	0.000596	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Conjugated Estrogens—osteoporosis	9.84e-05	0.000592	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	9.83e-05	0.000591	CcSEcCtD
Cyproterone acetate—Pruritus—Estropipate—osteoporosis	9.78e-05	0.000588	CcSEcCtD
Cyproterone acetate—Discomfort—Zoledronate—osteoporosis	9.78e-05	0.000588	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.77e-05	0.00405	CbGpPWpGaD
Cyproterone acetate—Asthenia—Alendronate—osteoporosis	9.77e-05	0.000588	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Ibandronate—osteoporosis	9.77e-05	0.000588	CcSEcCtD
Cyproterone acetate—Cough—Conjugated Estrogens—osteoporosis	9.77e-05	0.000588	CcSEcCtD
Cyproterone acetate—Dyspnoea—Risedronate—osteoporosis	9.74e-05	0.000586	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Estradiol—osteoporosis	9.73e-05	0.000585	CcSEcCtD
Cyproterone acetate—Hypotension—Pamidronate—osteoporosis	9.7e-05	0.000584	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	9.67e-05	0.000582	CcSEcCtD
Cyproterone acetate—Fatigue—Ethinyl Estradiol—osteoporosis	9.66e-05	0.000581	CcSEcCtD
Cyproterone acetate—Pruritus—Alendronate—osteoporosis	9.63e-05	0.000579	CcSEcCtD
Cyproterone acetate—Dyspepsia—Risedronate—osteoporosis	9.62e-05	0.000578	CcSEcCtD
Cyproterone acetate—Eye disorder—Estradiol—osteoporosis	9.62e-05	0.000578	CcSEcCtD
Cyproterone acetate—Constipation—Ethinyl Estradiol—osteoporosis	9.58e-05	0.000576	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Calcitriol—osteoporosis	9.56e-05	0.000575	CcSEcCtD
Cyproterone acetate—Asthenia—Ibandronate—osteoporosis	9.51e-05	0.000572	CcSEcCtD
Cyproterone acetate—Nausea—Etidronic acid—osteoporosis	9.49e-05	0.000571	CcSEcCtD
Cyproterone acetate—Oedema—Zoledronate—osteoporosis	9.49e-05	0.000571	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9.46e-05	0.000569	CcSEcCtD
Cyproterone acetate—Diarrhoea—Estropipate—osteoporosis	9.46e-05	0.000569	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Risedronate—osteoporosis	9.43e-05	0.000567	CcSEcCtD
Cyproterone acetate—Fatigue—Risedronate—osteoporosis	9.42e-05	0.000567	CcSEcCtD
Cyproterone acetate—Pruritus—Ibandronate—osteoporosis	9.38e-05	0.000564	CcSEcCtD
Cyproterone acetate—Constipation—Risedronate—osteoporosis	9.34e-05	0.000562	CcSEcCtD
Cyproterone acetate—Angiopathy—Estradiol—osteoporosis	9.34e-05	0.000562	CcSEcCtD
Cyproterone acetate—Shock—Zoledronate—osteoporosis	9.33e-05	0.000561	CcSEcCtD
Cyproterone acetate—Diarrhoea—Alendronate—osteoporosis	9.32e-05	0.00056	CcSEcCtD
Cyproterone acetate—Asthenia—Calcitriol—osteoporosis	9.31e-05	0.00056	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Zoledronate—osteoporosis	9.3e-05	0.00056	CcSEcCtD
Cyproterone acetate—Immune system disorder—Estradiol—osteoporosis	9.29e-05	0.000559	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Zoledronate—osteoporosis	9.29e-05	0.000559	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Estradiol—osteoporosis	9.27e-05	0.000558	CcSEcCtD
Cyproterone acetate—Dyspnoea—Pamidronate—osteoporosis	9.26e-05	0.000557	CcSEcCtD
Cyproterone acetate—Tachycardia—Zoledronate—osteoporosis	9.26e-05	0.000557	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	9.23e-05	0.000555	CcSEcCtD
Cyproterone acetate—Chills—Estradiol—osteoporosis	9.23e-05	0.000555	CcSEcCtD
Cyproterone acetate—Skin disorder—Zoledronate—osteoporosis	9.21e-05	0.000554	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ESR1—osteoporosis	9.21e-05	0.00381	CbGpPWpGaD
Cyproterone acetate—Pruritus—Calcitriol—osteoporosis	9.18e-05	0.000552	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Zoledronate—osteoporosis	9.17e-05	0.000552	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.16e-05	0.000551	CcSEcCtD
Cyproterone acetate—Diarrhoea—Raloxifene—osteoporosis	9.16e-05	0.000551	CcSEcCtD
Cyproterone acetate—Dyspepsia—Pamidronate—osteoporosis	9.14e-05	0.00055	CcSEcCtD
Cyproterone acetate—Dizziness—Estropipate—osteoporosis	9.14e-05	0.00055	CcSEcCtD
Cyproterone acetate—Oedema—Conjugated Estrogens—osteoporosis	9.13e-05	0.000549	CcSEcCtD
Cyproterone acetate—Alopecia—Estradiol—osteoporosis	9.09e-05	0.000547	CcSEcCtD
Cyproterone acetate—Diarrhoea—Ibandronate—osteoporosis	9.07e-05	0.000546	CcSEcCtD
Cyproterone acetate—Anorexia—Zoledronate—osteoporosis	9.04e-05	0.000544	CcSEcCtD
Cyproterone acetate—Decreased appetite—Pamidronate—osteoporosis	9.03e-05	0.000543	CcSEcCtD
Cyproterone acetate—Mental disorder—Estradiol—osteoporosis	9.01e-05	0.000542	CcSEcCtD
Cyproterone acetate—Dizziness—Alendronate—osteoporosis	9e-05	0.000542	CcSEcCtD
Cyproterone acetate—Shock—Conjugated Estrogens—osteoporosis	8.99e-05	0.000541	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Pamidronate—osteoporosis	8.97e-05	0.000539	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Conjugated Estrogens—osteoporosis	8.96e-05	0.000539	CcSEcCtD
Cyproterone acetate—Malnutrition—Estradiol—osteoporosis	8.96e-05	0.000539	CcSEcCtD
Cyproterone acetate—Fatigue—Pamidronate—osteoporosis	8.95e-05	0.000539	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Risedronate—osteoporosis	8.93e-05	0.000537	CcSEcCtD
Cyproterone acetate—Tachycardia—Conjugated Estrogens—osteoporosis	8.91e-05	0.000536	CcSEcCtD
Cyproterone acetate—Urticaria—Ethinyl Estradiol—osteoporosis	8.9e-05	0.000535	CcSEcCtD
Cyproterone acetate—Constipation—Pamidronate—osteoporosis	8.88e-05	0.000534	CcSEcCtD
Cyproterone acetate—Diarrhoea—Calcitriol—osteoporosis	8.88e-05	0.000534	CcSEcCtD
Cyproterone acetate—Skin disorder—Conjugated Estrogens—osteoporosis	8.87e-05	0.000534	CcSEcCtD
Cyproterone acetate—Hypotension—Zoledronate—osteoporosis	8.86e-05	0.000533	CcSEcCtD
Cyproterone acetate—Abdominal pain—Ethinyl Estradiol—osteoporosis	8.86e-05	0.000533	CcSEcCtD
Cyproterone acetate—Body temperature increased—Ethinyl Estradiol—osteoporosis	8.86e-05	0.000533	CcSEcCtD
Cyproterone acetate—Dizziness—Raloxifene—osteoporosis	8.85e-05	0.000533	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	8.83e-05	0.000531	CcSEcCtD
Cyproterone acetate—Tension—Estradiol—osteoporosis	8.79e-05	0.000529	CcSEcCtD
Cyproterone acetate—Vomiting—Estropipate—osteoporosis	8.79e-05	0.000529	CcSEcCtD
Cyproterone acetate—Dizziness—Ibandronate—osteoporosis	8.77e-05	0.000527	CcSEcCtD
Cyproterone acetate—Rash—Estropipate—osteoporosis	8.72e-05	0.000524	CcSEcCtD
Cyproterone acetate—Dermatitis—Estropipate—osteoporosis	8.71e-05	0.000524	CcSEcCtD
Cyproterone acetate—Anorexia—Conjugated Estrogens—osteoporosis	8.71e-05	0.000524	CcSEcCtD
Cyproterone acetate—Urticaria—Risedronate—osteoporosis	8.68e-05	0.000522	CcSEcCtD
Cyproterone acetate—Headache—Estropipate—osteoporosis	8.66e-05	0.000521	CcSEcCtD
Cyproterone acetate—Vomiting—Alendronate—osteoporosis	8.66e-05	0.000521	CcSEcCtD
Cyproterone acetate—Body temperature increased—Risedronate—osteoporosis	8.64e-05	0.00052	CcSEcCtD
Cyproterone acetate—Abdominal pain—Risedronate—osteoporosis	8.64e-05	0.00052	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—IRS1—osteoporosis	8.6e-05	0.00356	CbGpPWpGaD
Cyproterone acetate—Rash—Alendronate—osteoporosis	8.58e-05	0.000516	CcSEcCtD
Cyproterone acetate—Dermatitis—Alendronate—osteoporosis	8.58e-05	0.000516	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Pamidronate—osteoporosis	8.56e-05	0.000515	CcSEcCtD
Cyproterone acetate—Hypotension—Conjugated Estrogens—osteoporosis	8.53e-05	0.000513	CcSEcCtD
Cyproterone acetate—Headache—Alendronate—osteoporosis	8.53e-05	0.000513	CcSEcCtD
Cyproterone acetate—Vomiting—Raloxifene—osteoporosis	8.51e-05	0.000512	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Pamidronate—osteoporosis	8.49e-05	0.000511	CcSEcCtD
Cyproterone acetate—Dyspnoea—Zoledronate—osteoporosis	8.46e-05	0.000509	CcSEcCtD
Cyproterone acetate—Rash—Raloxifene—osteoporosis	8.44e-05	0.000508	CcSEcCtD
Cyproterone acetate—Dermatitis—Raloxifene—osteoporosis	8.43e-05	0.000507	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IRS2—osteoporosis	8.43e-05	0.00349	CbGpPWpGaD
Cyproterone acetate—Vomiting—Ibandronate—osteoporosis	8.43e-05	0.000507	CcSEcCtD
Cyproterone acetate—Headache—Raloxifene—osteoporosis	8.39e-05	0.000505	CcSEcCtD
Cyproterone acetate—Rash—Ibandronate—osteoporosis	8.36e-05	0.000503	CcSEcCtD
Cyproterone acetate—Dermatitis—Ibandronate—osteoporosis	8.35e-05	0.000502	CcSEcCtD
Cyproterone acetate—Dyspepsia—Zoledronate—osteoporosis	8.35e-05	0.000502	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Estradiol—osteoporosis	8.31e-05	0.0005	CcSEcCtD
Cyproterone acetate—Headache—Ibandronate—osteoporosis	8.3e-05	0.0005	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.25e-05	0.000497	CcSEcCtD
Cyproterone acetate—Vomiting—Calcitriol—osteoporosis	8.25e-05	0.000496	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—osteoporosis	8.25e-05	0.00341	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Zoledronate—osteoporosis	8.25e-05	0.000496	CcSEcCtD
Cyproterone acetate—Agitation—Estradiol—osteoporosis	8.23e-05	0.000495	CcSEcCtD
Cyproterone acetate—Nausea—Estropipate—osteoporosis	8.21e-05	0.000494	CcSEcCtD
Cyproterone acetate—Abdominal pain—Pamidronate—osteoporosis	8.21e-05	0.000494	CcSEcCtD
Cyproterone acetate—Body temperature increased—Pamidronate—osteoporosis	8.21e-05	0.000494	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Zoledronate—osteoporosis	8.19e-05	0.000493	CcSEcCtD
Cyproterone acetate—Rash—Calcitriol—osteoporosis	8.18e-05	0.000492	CcSEcCtD
Cyproterone acetate—Fatigue—Zoledronate—osteoporosis	8.18e-05	0.000492	CcSEcCtD
Cyproterone acetate—Dermatitis—Calcitriol—osteoporosis	8.17e-05	0.000492	CcSEcCtD
Cyproterone acetate—Dyspnoea—Conjugated Estrogens—osteoporosis	8.14e-05	0.00049	CcSEcCtD
Cyproterone acetate—Headache—Calcitriol—osteoporosis	8.13e-05	0.000489	CcSEcCtD
Cyproterone acetate—Constipation—Zoledronate—osteoporosis	8.11e-05	0.000488	CcSEcCtD
Cyproterone acetate—Nausea—Alendronate—osteoporosis	8.09e-05	0.000487	CcSEcCtD
Cyproterone acetate—Malaise—Estradiol—osteoporosis	8.08e-05	0.000486	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Risedronate—osteoporosis	8.05e-05	0.000484	CcSEcCtD
Cyproterone acetate—Dyspepsia—Conjugated Estrogens—osteoporosis	8.04e-05	0.000484	CcSEcCtD
Cyproterone acetate—Asthenia—Ethinyl Estradiol—osteoporosis	8.04e-05	0.000484	CcSEcCtD
Cyproterone acetate—Syncope—Estradiol—osteoporosis	8.03e-05	0.000483	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	7.96e-05	0.0033	CbGpPWpGaD
Cyproterone acetate—Nausea—Raloxifene—osteoporosis	7.95e-05	0.000478	CcSEcCtD
Cyproterone acetate—Decreased appetite—Conjugated Estrogens—osteoporosis	7.94e-05	0.000478	CcSEcCtD
Cyproterone acetate—Pruritus—Ethinyl Estradiol—osteoporosis	7.93e-05	0.000477	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoporosis	7.92e-05	0.00328	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	7.89e-05	0.000474	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	7.88e-05	0.00326	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6R—osteoporosis	7.87e-05	0.00326	CbGpPWpGaD
Cyproterone acetate—Fatigue—Conjugated Estrogens—osteoporosis	7.87e-05	0.000474	CcSEcCtD
Cyproterone acetate—Nausea—Ibandronate—osteoporosis	7.87e-05	0.000474	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Estradiol—osteoporosis	7.87e-05	0.000474	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—U2AF1—osteoporosis	7.85e-05	0.00325	CbGpPWpGaD
Cyproterone acetate—Asthenia—Risedronate—osteoporosis	7.84e-05	0.000472	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Zoledronate—osteoporosis	7.82e-05	0.00047	CcSEcCtD
Cyproterone acetate—Cough—Estradiol—osteoporosis	7.82e-05	0.00047	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.81e-05	0.00323	CbGpPWpGaD
Cyproterone acetate—Constipation—Conjugated Estrogens—osteoporosis	7.81e-05	0.00047	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Zoledronate—osteoporosis	7.76e-05	0.000467	CcSEcCtD
Cyproterone acetate—Pruritus—Risedronate—osteoporosis	7.73e-05	0.000465	CcSEcCtD
Cyproterone acetate—Nausea—Calcitriol—osteoporosis	7.71e-05	0.000464	CcSEcCtD
Cyproterone acetate—Diarrhoea—Ethinyl Estradiol—osteoporosis	7.67e-05	0.000461	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Pamidronate—osteoporosis	7.65e-05	0.00046	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	7.63e-05	0.00316	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.57e-05	0.000456	CcSEcCtD
Cyproterone acetate—Urticaria—Zoledronate—osteoporosis	7.54e-05	0.000453	CcSEcCtD
Cyproterone acetate—Discomfort—Estradiol—osteoporosis	7.53e-05	0.000453	CcSEcCtD
Cyproterone acetate—Body temperature increased—Zoledronate—osteoporosis	7.5e-05	0.000451	CcSEcCtD
Cyproterone acetate—Abdominal pain—Zoledronate—osteoporosis	7.5e-05	0.000451	CcSEcCtD
Cyproterone acetate—Diarrhoea—Risedronate—osteoporosis	7.47e-05	0.00045	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.47e-05	0.000449	CcSEcCtD
Cyproterone acetate—Asthenia—Pamidronate—osteoporosis	7.45e-05	0.000448	CcSEcCtD
Cyproterone acetate—Dizziness—Ethinyl Estradiol—osteoporosis	7.41e-05	0.000446	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	7.4e-05	0.00306	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IRS1—osteoporosis	7.36e-05	0.00305	CbGpPWpGaD
Cyproterone acetate—Pruritus—Pamidronate—osteoporosis	7.35e-05	0.000442	CcSEcCtD
Cyproterone acetate—Oedema—Estradiol—osteoporosis	7.31e-05	0.00044	CcSEcCtD
Cyproterone acetate—Urticaria—Conjugated Estrogens—osteoporosis	7.26e-05	0.000437	CcSEcCtD
Cyproterone acetate—Dizziness—Risedronate—osteoporosis	7.22e-05	0.000435	CcSEcCtD
Cyproterone acetate—Body temperature increased—Conjugated Estrogens—osteoporosis	7.22e-05	0.000434	CcSEcCtD
Cyproterone acetate—Abdominal pain—Conjugated Estrogens—osteoporosis	7.22e-05	0.000434	CcSEcCtD
Cyproterone acetate—Shock—Estradiol—osteoporosis	7.19e-05	0.000433	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Estradiol—osteoporosis	7.17e-05	0.000431	CcSEcCtD
Cyproterone acetate—Tachycardia—Estradiol—osteoporosis	7.13e-05	0.000429	CcSEcCtD
Cyproterone acetate—Vomiting—Ethinyl Estradiol—osteoporosis	7.12e-05	0.000429	CcSEcCtD
Cyproterone acetate—Diarrhoea—Pamidronate—osteoporosis	7.11e-05	0.000427	CcSEcCtD
Cyproterone acetate—Skin disorder—Estradiol—osteoporosis	7.1e-05	0.000427	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Estradiol—osteoporosis	7.07e-05	0.000425	CcSEcCtD
Cyproterone acetate—Rash—Ethinyl Estradiol—osteoporosis	7.06e-05	0.000425	CcSEcCtD
Cyproterone acetate—Dermatitis—Ethinyl Estradiol—osteoporosis	7.06e-05	0.000425	CcSEcCtD
Cyproterone acetate—Headache—Ethinyl Estradiol—osteoporosis	7.02e-05	0.000422	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Zoledronate—osteoporosis	6.99e-05	0.00042	CcSEcCtD
Cyproterone acetate—Vomiting—Risedronate—osteoporosis	6.95e-05	0.000418	CcSEcCtD
Cyproterone acetate—Rash—Risedronate—osteoporosis	6.89e-05	0.000414	CcSEcCtD
Cyproterone acetate—Dermatitis—Risedronate—osteoporosis	6.88e-05	0.000414	CcSEcCtD
Cyproterone acetate—Dizziness—Pamidronate—osteoporosis	6.87e-05	0.000413	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	6.86e-05	0.00284	CbGpPWpGaD
Cyproterone acetate—Headache—Risedronate—osteoporosis	6.84e-05	0.000412	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IGF1—osteoporosis	6.82e-05	0.00282	CbGpPWpGaD
Cyproterone acetate—Asthenia—Zoledronate—osteoporosis	6.81e-05	0.000409	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Conjugated Estrogens—osteoporosis	6.73e-05	0.000405	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	6.72e-05	0.00278	CbGpPWpGaD
Cyproterone acetate—Pruritus—Zoledronate—osteoporosis	6.71e-05	0.000404	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	6.71e-05	0.00277	CbGpPWpGaD
Cyproterone acetate—Nausea—Ethinyl Estradiol—osteoporosis	6.66e-05	0.0004	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.64e-05	0.00275	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	6.6e-05	0.00273	CbGpPWpGaD
Cyproterone acetate—Vomiting—Pamidronate—osteoporosis	6.6e-05	0.000397	CcSEcCtD
Cyproterone acetate—Asthenia—Conjugated Estrogens—osteoporosis	6.55e-05	0.000394	CcSEcCtD
Cyproterone acetate—Rash—Pamidronate—osteoporosis	6.55e-05	0.000394	CcSEcCtD
Cyproterone acetate—Dermatitis—Pamidronate—osteoporosis	6.54e-05	0.000394	CcSEcCtD
Cyproterone acetate—Dyspnoea—Estradiol—osteoporosis	6.52e-05	0.000392	CcSEcCtD
Cyproterone acetate—Headache—Pamidronate—osteoporosis	6.51e-05	0.000391	CcSEcCtD
Cyproterone acetate—Diarrhoea—Zoledronate—osteoporosis	6.49e-05	0.00039	CcSEcCtD
Cyproterone acetate—Nausea—Risedronate—osteoporosis	6.49e-05	0.00039	CcSEcCtD
Cyproterone acetate—Pruritus—Conjugated Estrogens—osteoporosis	6.46e-05	0.000389	CcSEcCtD
Cyproterone acetate—Dyspepsia—Estradiol—osteoporosis	6.43e-05	0.000387	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—osteoporosis	6.42e-05	0.00266	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Estradiol—osteoporosis	6.35e-05	0.000382	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Estradiol—osteoporosis	6.31e-05	0.00038	CcSEcCtD
Cyproterone acetate—Fatigue—Estradiol—osteoporosis	6.3e-05	0.000379	CcSEcCtD
Cyproterone acetate—Dizziness—Zoledronate—osteoporosis	6.27e-05	0.000377	CcSEcCtD
Cyproterone acetate—Constipation—Estradiol—osteoporosis	6.25e-05	0.000376	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR2—osteoporosis	6.25e-05	0.00259	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Conjugated Estrogens—osteoporosis	6.25e-05	0.000376	CcSEcCtD
Cyproterone acetate—Nausea—Pamidronate—osteoporosis	6.17e-05	0.000371	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PKM—osteoporosis	6.06e-05	0.00251	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FDPS—osteoporosis	6.06e-05	0.00251	CbGpPWpGaD
Cyproterone acetate—Dizziness—Conjugated Estrogens—osteoporosis	6.04e-05	0.000363	CcSEcCtD
Cyproterone acetate—Vomiting—Zoledronate—osteoporosis	6.03e-05	0.000363	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Estradiol—osteoporosis	6.02e-05	0.000362	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	5.99e-05	0.00248	CbGpPWpGaD
Cyproterone acetate—Rash—Zoledronate—osteoporosis	5.98e-05	0.00036	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	5.98e-05	0.00248	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Estradiol—osteoporosis	5.98e-05	0.00036	CcSEcCtD
Cyproterone acetate—Dermatitis—Zoledronate—osteoporosis	5.98e-05	0.000359	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	5.97e-05	0.00247	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—U2AF1—osteoporosis	5.96e-05	0.00247	CbGpPWpGaD
Cyproterone acetate—Headache—Zoledronate—osteoporosis	5.94e-05	0.000357	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—RPL24—osteoporosis	5.84e-05	0.00242	CbGpPWpGaD
Cyproterone acetate—Vomiting—Conjugated Estrogens—osteoporosis	5.81e-05	0.000349	CcSEcCtD
Cyproterone acetate—Urticaria—Estradiol—osteoporosis	5.81e-05	0.000349	CcSEcCtD
Cyproterone acetate—Body temperature increased—Estradiol—osteoporosis	5.78e-05	0.000348	CcSEcCtD
Cyproterone acetate—Abdominal pain—Estradiol—osteoporosis	5.78e-05	0.000348	CcSEcCtD
Cyproterone acetate—Rash—Conjugated Estrogens—osteoporosis	5.76e-05	0.000346	CcSEcCtD
Cyproterone acetate—Dermatitis—Conjugated Estrogens—osteoporosis	5.75e-05	0.000346	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PGLS—osteoporosis	5.74e-05	0.00238	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPD2—osteoporosis	5.74e-05	0.00238	CbGpPWpGaD
Cyproterone acetate—Headache—Conjugated Estrogens—osteoporosis	5.72e-05	0.000344	CcSEcCtD
Cyproterone acetate—Nausea—Zoledronate—osteoporosis	5.63e-05	0.000339	CcSEcCtD
Cyproterone acetate—Nausea—Conjugated Estrogens—osteoporosis	5.43e-05	0.000326	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Estradiol—osteoporosis	5.39e-05	0.000324	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PNP—osteoporosis	5.25e-05	0.00217	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ATIC—osteoporosis	5.25e-05	0.00217	CbGpPWpGaD
Cyproterone acetate—Asthenia—Estradiol—osteoporosis	5.24e-05	0.000316	CcSEcCtD
Cyproterone acetate—Pruritus—Estradiol—osteoporosis	5.17e-05	0.000311	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	5.05e-05	0.00209	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Estradiol—osteoporosis	5e-05	0.000301	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—osteoporosis	4.96e-05	0.00205	CbGpPWpGaD
Cyproterone acetate—Dizziness—Estradiol—osteoporosis	4.83e-05	0.000291	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	4.79e-05	0.00198	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	4.74e-05	0.00196	CbGpPWpGaD
Cyproterone acetate—Vomiting—Estradiol—osteoporosis	4.65e-05	0.00028	CcSEcCtD
Cyproterone acetate—Rash—Estradiol—osteoporosis	4.61e-05	0.000277	CcSEcCtD
Cyproterone acetate—Dermatitis—Estradiol—osteoporosis	4.6e-05	0.000277	CcSEcCtD
Cyproterone acetate—Headache—Estradiol—osteoporosis	4.58e-05	0.000275	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	4.54e-05	0.00188	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—OXCT1—osteoporosis	4.47e-05	0.00185	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA2—osteoporosis	4.47e-05	0.00185	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	4.45e-05	0.00184	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL24—osteoporosis	4.43e-05	0.00183	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MGLL—osteoporosis	4.35e-05	0.0018	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	4.35e-05	0.0018	CbGpPWpGaD
Cyproterone acetate—Nausea—Estradiol—osteoporosis	4.34e-05	0.000261	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	4.12e-05	0.00171	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—osteoporosis	4.09e-05	0.00169	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.97e-05	0.00164	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.96e-05	0.00164	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—osteoporosis	3.82e-05	0.00158	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—osteoporosis	3.79e-05	0.00157	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	3.76e-05	0.00156	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—IDH2—osteoporosis	3.7e-05	0.00153	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.7e-05	0.00153	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	3.51e-05	0.00145	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP27A1—osteoporosis	3.48e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACP5—osteoporosis	3.39e-05	0.0014	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PSMA2—osteoporosis	3.37e-05	0.00139	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PSMA5—osteoporosis	3.37e-05	0.00139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.34e-05	0.00138	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	3.3e-05	0.00136	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TPI1—osteoporosis	3.15e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—osteoporosis	3.08e-05	0.00127	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR2—osteoporosis	3.01e-05	0.00125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—P4HB—osteoporosis	2.96e-05	0.00122	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GAPDH—osteoporosis	2.9e-05	0.0012	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	2.88e-05	0.00119	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—RAP1A—osteoporosis	2.83e-05	0.00117	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	2.66e-05	0.0011	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PSMA2—osteoporosis	2.55e-05	0.00106	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PSMA5—osteoporosis	2.55e-05	0.00106	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.47e-05	0.00102	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—osteoporosis	2.39e-05	0.000988	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO1—osteoporosis	2.29e-05	0.000946	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR2—osteoporosis	2.28e-05	0.000945	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PSMA2—osteoporosis	2.25e-05	0.000933	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PSMA5—osteoporosis	2.25e-05	0.000933	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—osteoporosis	1.97e-05	0.000816	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—osteoporosis	1.82e-05	0.000755	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—osteoporosis	1.81e-05	0.00075	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	1.5e-05	0.000619	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADCY5—osteoporosis	1.49e-05	0.000618	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—osteoporosis	1.49e-05	0.000616	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—osteoporosis	1.38e-05	0.000573	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—osteoporosis	1.37e-05	0.000569	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—osteoporosis	1.1e-05	0.000455	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—osteoporosis	9.49e-06	0.000393	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—osteoporosis	7.2e-06	0.000298	CbGpPWpGaD
